These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 11035102

  • 21. The chemoattractant Trp-Lys-Tyr-Met-Val-D-Met activates eosinophils through the formyl peptide receptor and one of its homologues, formyl peptide receptor-like 1.
    Svensson L, Dahlgren C, Wennerås C.
    J Leukoc Biol; 2002 Oct; 72(4):810-8. PubMed ID: 12377951
    [Abstract] [Full Text] [Related]

  • 22. Histamine inhibits neutrophil NADPH oxidase activity triggered by the lipoxin A4 receptor-specific peptide agonist Trp-Lys-Tyr-Met-Val-Met.
    Betten A, Dahlgren C, Hermodsson S, Hellstrand K.
    Scand J Immunol; 2003 Sep; 58(3):321-6. PubMed ID: 12950678
    [Abstract] [Full Text] [Related]

  • 23. The immunosuppressant cyclosporin A antagonizes human formyl peptide receptor through inhibition of cognate ligand binding.
    Yan P, Nanamori M, Sun M, Zhou C, Cheng N, Li N, Zheng W, Xiao L, Xie X, Ye RD, Wang MW.
    J Immunol; 2006 Nov 15; 177(10):7050-8. PubMed ID: 17082621
    [Abstract] [Full Text] [Related]

  • 24. N-Formyl peptide receptor ligation induces rac-dependent actin reorganization through Gbeta gamma subunits and class Ia phosphoinositide 3-kinases.
    Belisle B, Abo A.
    J Biol Chem; 2000 Aug 25; 275(34):26225-32. PubMed ID: 10843992
    [Abstract] [Full Text] [Related]

  • 25. Receptor-induced translocation of activated guanine-nucleotide-binding protein alpha i subunits to the cytoskeleton in myeloid differentiated human leukemia (HL-60) cells.
    Wieland T, Meyer zu Heringdorf D, Schulze RA, Kaldenberg-Stasch S, Jakobs KH.
    Eur J Biochem; 1996 Aug 01; 239(3):752-8. PubMed ID: 8774723
    [Abstract] [Full Text] [Related]

  • 26. Functional expression of formyl peptide receptor family in human NK cells.
    Kim SD, Kim JM, Jo SH, Lee HY, Lee SY, Shim JW, Seo SK, Yun J, Bae YS.
    J Immunol; 2009 Nov 01; 183(9):5511-7. PubMed ID: 19843937
    [Abstract] [Full Text] [Related]

  • 27. Stimulation of human formyl peptide receptors by calpain inhibitors: homology modeling of receptors and ligand docking simulation.
    Fujita H, Kato T, Watanabe N, Takahashi T, Kitagawa S.
    Arch Biochem Biophys; 2011 Dec 15; 516(2):121-7. PubMed ID: 22005393
    [Abstract] [Full Text] [Related]

  • 28. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils.
    Bae YS, Park JC, He R, Ye RD, Kwak JY, Suh PG, Ho Ryu S.
    Mol Pharmacol; 2003 Sep 15; 64(3):721-30. PubMed ID: 12920210
    [Abstract] [Full Text] [Related]

  • 29. Ligand-induced adhesion to activated endothelium and to vascular cell adhesion molecule-1 in lymphocytes transfected with the N-formyl peptide receptor.
    Honda S, Campbell JJ, Andrew DP, Engelhardt B, Butcher BA, Warnock RA, Ye RD, Butcher EC.
    J Immunol; 1994 Apr 15; 152(8):4026-35. PubMed ID: 7511663
    [Abstract] [Full Text] [Related]

  • 30. Discovery of Trp-Nle-Tyr-Met as a novel agonist for human formyl peptide receptor-like 1.
    Wan HX, Zhou C, Zhang Y, Sun M, Wang X, Yu H, Yang X, Ye RD, Shen JK, Wang MW.
    Biochem Pharmacol; 2007 Jul 15; 74(2):317-26. PubMed ID: 17517377
    [Abstract] [Full Text] [Related]

  • 31. A high potency nonformylated peptide agonist for the phagocyte N-formylpeptide chemotactic receptor.
    Gao JL, Becker EL, Freer RJ, Muthukumaraswamy N, Murphy PM.
    J Exp Med; 1994 Dec 01; 180(6):2191-7. PubMed ID: 7964494
    [Abstract] [Full Text] [Related]

  • 32. Low-affinity receptor-mediated induction of superoxide by N-formyl-methionyl-leucyl-phenylalanine and WKYMVm in IMR90 human fibroblasts.
    Ammendola R, Russo L, De Felice C, Esposito F, Russo T, Cimino F.
    Free Radic Biol Med; 2004 Jan 15; 36(2):189-200. PubMed ID: 14744631
    [Abstract] [Full Text] [Related]

  • 33. A novel nonpeptide ligand for formyl peptide receptor-like 1.
    Nanamori M, Cheng X, Mei J, Sang H, Xuan Y, Zhou C, Wang MW, Ye RD.
    Mol Pharmacol; 2004 Nov 15; 66(5):1213-22. PubMed ID: 15308762
    [Abstract] [Full Text] [Related]

  • 34. Functional capabilities of an N-formyl peptide receptor-G(alpha)(i)(2) fusion protein: assemblies with G proteins and arrestins.
    Shi M, Bennett TA, Cimino DF, Maestas DC, Foutz TD, Gurevich VV, Sklar LA, Prossnitz ER.
    Biochemistry; 2003 Jun 24; 42(24):7283-93. PubMed ID: 12809484
    [Abstract] [Full Text] [Related]

  • 35. The N-formylpeptide receptor (FPR) and a second G(i)-coupled receptor mediate fMet-Leu-Phe-stimulated activation of NADPH oxidase in murine neutrophils.
    Lavigne MC, Murphy PM, Leto TL, Gao JL.
    Cell Immunol; 2002 Jun 24; 218(1-2):7-12. PubMed ID: 12470609
    [Abstract] [Full Text] [Related]

  • 36. The ligand binding site of the formyl peptide receptor maps in the transmembrane region.
    Miettinen HM, Mills JS, Gripentrog JM, Dratz EA, Granger BL, Jesaitis AJ.
    J Immunol; 1997 Oct 15; 159(8):4045-54. PubMed ID: 9378994
    [Abstract] [Full Text] [Related]

  • 37. N-terminus urea-substituted chemotactic peptides: new potent agonists and antagonists toward the neutrophil fMLF receptor.
    Higgins JD, Bridger GJ, Derian CK, Beblavy MJ, Hernandez PE, Gaul FE, Abrams MJ, Pike MC, Solomon HF.
    J Med Chem; 1996 Mar 01; 39(5):1013-5. PubMed ID: 8676333
    [No Abstract] [Full Text] [Related]

  • 38. Differential coupling of the formyl peptide receptor to adenylate cyclase and phospholipase C by the pertussis toxin-insensitive Gz protein.
    Tsu RC, Lai HW, Allen RA, Wong YH.
    Biochem J; 1995 Jul 01; 309 ( Pt 1)(Pt 1):331-9. PubMed ID: 7619076
    [Abstract] [Full Text] [Related]

  • 39. Dual Mg2+ control of formyl-peptide-receptor--G-protein interaction in HL 60 cells. Evidence that the low-agonist-affinity receptor interacts with and activates the G-protein.
    Gierschik P, Steisslinger M, Sidiropoulos D, Herrmann E, Jakobs KH.
    Eur J Biochem; 1989 Jul 15; 183(1):97-105. PubMed ID: 2502402
    [Abstract] [Full Text] [Related]

  • 40. The HIV-1 cell entry inhibitor T-20 potently chemoattracts neutrophils by specifically activating the N-formylpeptide receptor.
    Hartt JK, Liang T, Sahagun-Ruiz A, Wang JM, Gao JL, Murphy PM.
    Biochem Biophys Res Commun; 2000 Jun 16; 272(3):699-704. PubMed ID: 10860818
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.